AngioScore, Inc. was founded in 2003 with the mission of developing, making and selling leading edge tools for endovascular therapy. The company’s senior management team has built and led successful companies in interventional cardiology, cardiac surgery and diabetes treatment. Our Medical Advisory Board is made up of thought leaders in interventional cardiology practice and research.

The AngioSculpt Scoring Balloon Catheter is AngioScore’s first product. There were 2.2 million coronary angioplasty procedures worldwide in 2004 representing an estimated $855 million in sales of balloon angioplasty catheters.

The AngioSculpt scoring balloon catheter is CE mark approved for routine use in coronary arteries as an alternative to traditional angioplasty balloons. Traditional balloon angioplasty catheters have evolved little over the past 15 years ago and have many limitations. The innovative design of the AngioSculpt Scoring Balloon Catheter and its superb clinical performance provides interventional cardiologists with a long-needed improvement over traditional angioplasty balloons, particularly in patients with complex lesions.

Page

For more than 80 years, the name Terumo® has been synonymous with innovative medical devices.

Terumo is now a comprehensive resource for peripheral embolization technologies. Terumo account representatives support a portfolio that includes Bead Block™ Compressible Microspheres, Progreat™ ? Microcatheters, Glidewire® GT Gold Coil Guidewires, Glidecath® XP Hydrophilic Coated Catheters, and Glidesheath™ Hydrophilic Coated Introducer Sheaths. These devices, as well as the company’s account services and customer support, offer the dependability, predictability, and consistency—the overall excellence— that have become the hallmarks of Terumo.

Home Page

The Arizona Heart Institute and Arizona Heart Hospital offering video podcasts site for Cardiovascular Education.

http://www.cvmd.org/

Merit’s products address the needs of cardiologists and radiologists around the world, enabling them to perform diagnostic and interventional procedures such as angiography, angioplasty, stent placement, AAA (stent grafts), discography, thrombolysis and other procedures. Merit’s product lines include balloon inflation devices and accessories, diagnostic and therapeutic catheters and guide wires, pressure monitoring disposables, fluid delivery systems, medication syringes, safety products, and needles. Merit currently offers over 2,000 FDA-cleared devices, participating in a market estimated to be over $1 billion annually.

Home page

IDev Technologies, Inc. is an Innovator and Developer of next generation medical devices for use in the interventional radiology, vascular surgery, and cardiology device marketplace. IDev Technologies, Inc.’s current portfolio contains over thirty technologies exclusively licensed from the M.D. Anderson Cancer Center representing over a $5.0 billion market opportunity.

IDev’s products currently available in the U.S. and European markets include the AKo’nya Eliminator™ Mechanical Thrombectomy Device, the Texan™ Foreign Body Retrieval Device, and the recently released AKo’nya Eliminator Plus™ Mechanical Thrombectomy Device. The SureSave™ Biliary Stent and Precision™ Stent-Delivery Catheter are expected to launch in late 2005.

Home page

The company has developed and is currently testing next generation alternatives for use in site-specific drug elution.

Home page